KEY HIGHLIGHTS

  • US-based Rare Earth Technologies Inc (RETi) confirms ABx's mixed rare earth carbonate (MREC) is high quality and suitable for proprietary separation process
  • ABx and RETi advancing discussions about commercial supply of MREC, representing potential near-term revenue opportunity for the company
  • Deep Leads Rare Earths Project in Tasmania contains ionic adsorption clay resource enabling low-cost extraction and high-quality MREC production
  • ABx Group is diversified across rare earths (Tasmania), clean fluorine chemicals (ALCORE pilot plant in Bell Bay), and near-term bauxite production (Queensland, New South Wales, Tasmania)
  • Bauxite supply agreements with Good Importing International generated $2.7 million initial payment, demonstrating revenue capability in adjacent materials sector

ABx Group Limited (ASX:ABX), an Australian materials company focused on delivering solutions for a cleaner future, announced on 20 March 2026 a significant milestone in its rare earth strategy. The company revealed that US-based Rare Earth Technologies Inc (RETi), a leading processor of rare earth materials, has formally assessed ABx's mixed rare earth carbonate (MREC) product and confirmed its high quality and suitability for RETi's proprietary separation process utilizing Solid-Phase Extraction (SPE) and High-Performance Liquid Chromatography (HPLC) technology.

This positive customer assessment represents a critical validation point for ABx Group's Deep Leads Rare Earths Project in northern Tasmania. During RETi's formal assessment, the MREC dissolved fully and yielded excellent results during cerium depletion and chromatographic separation trials. More importantly for ABx shareholders, the two companies are now advancing discussions regarding commercial supply of MREC, potentially establishing a meaningful revenue stream for the company in the global rare earth supply chain.

The announcement signals that ABx Group is progressing from exploration and development stage toward commercialization of its rare earth assets at a time when Western governments and corporations are actively seeking to diversify supply chains away from China, which currently controls approximately 80 percent of global rare earth processing capacity. For investors, the RETi validation offers tangible evidence that ABx's processing capabilities and product quality meet international standards.

ABOUT ABx GROUP: Materials Company Focused on Cleaner Future Solutions

ABx Group Limited (ASX:ABX), headquartered at Suite 2, Level 11, 385 Bourke Street, Melbourne, Victoria 3000, is an Australian materials company operating across three primary sectors: rare earth extraction and processing, clean fluorine chemical production, and bauxite mining. The company's vision is to deliver materials solutions that support the global transition toward sustainable energy, circular economy principles, and advanced manufacturing.

The company's three priority projects are:

  • Deep Leads Rare Earths Project (Tasmania) - An ionic adsorption clay rare earth resource characterized by low-cost extraction methodology and high MREC quality production capability. Ionic adsorption clays represent one of the most economically advantaged rare earth deposit types, particularly for production of mixed rare earth carbonates suitable for downstream processing.
  • ALCORE Clean Fluorine Chemical Production (Bell Bay, Tasmania) - A pilot plant initiative for production of clean fluorine chemicals addressing international regulatory requirements. This project targets replacement of legacy halogenated compounds with environmental-friendly alternatives, capturing demand from manufacturers transitioning to compliant chemistries.
  • Near-Term Bauxite Production (Queensland, New South Wales, Tasmania) - Mining operations established through supply agreements with Good Importing International. Bauxite represents a near-term revenue opportunity, with the company already receiving $2.7 million initial payment, demonstrating immediate commercialization capability.

The company is led by Dr Mark Cooksey, Managing Director and Chief Executive Officer, who brings extensive experience in materials extraction, processing technology, and project development. ABx Group's strategic focus on critical materials positions the company within global supply chain transition themes driven by renewable energy adoption, electrification, advanced manufacturing, and regulatory compliance.

WHY ABX STOCK IS MOVING: Positive MREC Assessment Validates Commercial Viability

ABx Group shares are moving in response to multiple positive catalysts embedded within the 20 March 2026 announcement. The RETi validation represents the first formal independent assessment from a US-based rare earth processor, and significantly advances the company's commercialization narrative:

  • Formal Customer Validation - RETi's confirmation that ABx MREC meets technical specifications and is suitable for proprietary separation processes represents a critical validation point. This assessment demonstrates that Deep Leads' geological characteristics translate into market-acceptable product quality. The technical performance (full dissolution, excellent chromatographic separation results, successful cerium depletion) provides tangible evidence of product viability.
  • Commercial Supply Discussions - The fact that ABx and RETi are now advancing commercial negotiations signals meaningful movement toward binding supply agreements. For an early-stage materials company, advancing from assessment to commercial discussions represents a significant inflection point in the commercialization timeline and suggests customer confidence in ABx's ability to deliver production-scale quantities.
  • US Customer Engagement - Establishing relationships with US-based processors directly addresses geopolitical demand for non-China rare earth sources. RETi's endorsement provides third-party validation that ABx's product is competitive in Western rare earth processing markets and acceptable to multinational customers.
  • Product Quality Evidence - The MREC's successful performance during SPE and HPLC processing, including full dissolution and excellent chromatographic separation results, provides technical evidence that Deep Leads resources can support high-quality production at scale. These are not theoretical projections but empirical test results.
  • Reduced Development Risk - The RETi validation reduces technical execution risk and demonstrates market pull for ABx's rare earth products. Rather than ABx pushing product into the market, this scenario shows a customer actively seeking supply, which is a favorable demand dynamic for early-stage suppliers.

INDUSTRY TRENDS: Western Governments Driving Rare Earth Supply Chain Diversification

ABx Group's timing is exceptionally favorable within broader global trends reshaping rare earth supply chains and critical minerals procurement. Multiple structural factors support increasing demand for alternative rare earth suppliers:

  • Critical Minerals Policy - The United States, European Union, Australia, and other Western governments have elevated rare earth procurement to national security and economic resilience priorities. Regulatory frameworks including the US Inflation Reduction Act and EU Critical Raw Materials Act increasingly require supply chain transparency, traceability, and non-China sourcing for defense contracting, renewable energy projects, and advanced manufacturing applications. These policies create mandatory demand for non-Chinese rare earth supplies.
  • Electrification Demand - Global adoption of electric vehicles, renewable energy generation (wind turbines, solar installations), and grid modernization technologies is driving rare earth demand to record levels. Rare earth elements are essential, non-substitutable components in electric motor permanent magnets, wind turbine generators, energy storage systems, and power electronics. The International Energy Agency projects rare earth demand will increase by 400-600 percent by 2040.
  • Supply Chain Concentration Risk - China's control of approximately 80 percent of global rare earth processing creates acute supply vulnerability for Western manufacturers. Companies including Tesla, BMW, Rolls-Royce, General Dynamics, and major defense contractors are actively seeking to qualify alternative suppliers. This customer pull creates favorable demand dynamics for new suppliers.
  • Price Volatility and Supply Disruptions - Rare earth prices have demonstrated significant volatility, with heavy rare earth elements commanding premium pricing due to supply scarcity. China has periodically imposed export restrictions and quotas, creating supply shocks that motivate Western manufacturers to develop alternative supply sources. Supply diversification pressure supports pricing power for new suppliers.

FINANCIAL PERFORMANCE: Early-Stage Commercialization Phase with Revenue Visibility

ABx Group remains in early commercialization phase, with the company in transition from pure exploration and development stage toward revenue generation. The bauxite segment is demonstrating immediate revenue capability, with the company having received $2.7 million initial payment from Good Importing International for bauxite supply agreements. This demonstrates tangible evidence that ABx can execute supply arrangements and generate near-term cash flow.

The company's capital requirements remain substantial, as rare earth processing project development, ALCORE pilot plant completion and scaling, and bauxite mining expansion all require ongoing capital investment. Financing needs are typical for materials companies in commercialization phase, and will depend upon equity capital markets, debt financing, and/or strategic partnerships. The RETi engagement potentially positions ABx for partnership or offtake agreement that could assist funding requirements and reduce capital burden on equity holders.

Early-stage materials companies typically operate at cash burn levels during development phase, with profitability emerging only after production reaches commercial scale. Investors should expect capital raises and/or dilution until revenue reaches meaningful levels. However, the bauxite segment demonstrates near-term revenue potential, which could reduce overall company cash burn and extend runway.

INVESTMENT RISKS: Development Execution and Market Realization Challenges

While the RETi validation is positive and signals meaningful progress, investors should recognize several material risks associated with ABx Group investment:

  • Development and Scaling Risk - Deep Leads and ALCORE projects remain in early development stage. Scaling from assessment and pilot operations to commercial production involves technical, permitting, operational, and cost risks. Processing yield, cost, and product consistency at production scale may differ from early assessment results. Pilot plant performance does not guarantee commercial-scale economics.
  • Customer Concentration Risk - RETi represents a potential key customer, but the company does not currently have binding supply agreements. If supply discussions fail or are terminated, the company would need to identify alternative customers. Early-stage suppliers are often dependent upon single or few customers during commercialization, creating revenue concentration risk.
  • Commodity Price Risk - Rare earth element prices fluctuate based on global supply and demand dynamics. Sustained price declines could impact project economics and customer demand. Pricing for MREC and other rare earth products is subject to global market forces beyond ABx's control.
  • Funding and Capital Risk - Completion of project development and commercial-scale production requires ongoing capital funding. If equity markets become unfavorable or strategic partners decline participation, the company may face capital constraints limiting execution capability and forcing dilutive equity raises or unfavorable debt terms.
  • Regulatory and Permitting Risk - Mining and processing operations are subject to environmental permitting, Aboriginal heritage protections, labor regulations, and environmental compliance requirements. Changes in environmental regulations, climate policies, or permitting timelines could impact project economics and delay commercialization.

FUTURE GROWTH DRIVERS: RETi Supply Agreement, ALCORE Pilot, and Bauxite Ramp-Up

ABx Group's near-term and medium-term catalysts center on three commercialization milestones that could significantly impact shareholder value:

  • RETi Supply Agreement Execution - A binding supply agreement with RETi would represent significant validation and provide long-term revenue visibility. Supply agreement terms including volumes, pricing, duration, payment terms, and price adjustment mechanisms will be critical to valuation impact. A multi-year offtake agreement would provide revenue certainty and potentially unlock project financing.
  • ALCORE Pilot Plant Operations and Scaling - Completion of ALCORE pilot phase and progression to demonstration or commercial scale would add diversified revenue stream. Clean fluorine chemicals market is addressing regulatory requirements for manufacturers transitioning away from legacy halogenated compounds. Success in commercialization could establish second material revenue pillar.
  • Bauxite Production Ramp-Up and Contract Expansion - Expansion of bauxite mining operations across multiple Australian jurisdictions would accelerate revenue growth. The $2.7 million initial payment demonstrates market demand and validates supply agreements. Additional bauxite contracts or increased volumes would provide near-term cash flow.

ANALYST OUTLOOK: Rare Earth Market Positioning Strengthens Among Western Suppliers

Market sentiment regarding ABx Group appears to be improving based on validation progress and commercialization milestones. The RETi assessment represents tangible evidence of product quality and customer engagement, reducing execution risk uncertainty. For investors with conviction in the rare earth supply chain diversification theme, ABx Group's geographic advantage (Australian rare earth assets), demonstrated product quality (RETi validation), and diversified project portfolio position the company favorably within emerging Western rare earth suppliers.

Comparables within the rare earth sector demonstrate substantial valuation multiples based on reserve base, processed product quality, customer relationships, and near-term commercialization prospects. Companies with validated supply relationships and strategic customer partnerships typically command significant premiums to pure exploration companies. ABx Group's combination of RETi engagement and demonstrated bauxite revenue capability distinguishes it from earlier-stage peers.

CONCLUSION: RETi Validation Marks Inflection Point in ABx Group's Commercialization Timeline

ABx Group Limited's announcement of positive mixed rare earth carbonate validation from US-based Rare Earth Technologies Inc represents a significant inflection point in the company's development trajectory. For the first time, an independent US rare earth processor has formally confirmed that ABx's Deep Leads MREC product meets technical specifications and is suitable for commercial processing. This validation significantly reduces execution risk and provides empirical evidence that the Deep Leads resource can support commercially viable rare earth production.

More importantly, ABx and RETi are advancing commercial supply discussions, signaling movement toward binding supply agreements. Within the context of Western governments actively pursuing rare earth supply chain diversification away from China, global demand for rare earth elements accelerating due to electrification, and corporate customers seeking alternative supply sources, ABx Group's timing appears exceptionally favorable. The company's diversified portfolio spanning rare earths, clean fluorine chemicals, and bauxite production positions ABx to capture multiple materials supply chain opportunities.

However, investors must maintain realistic assessment of development risks and commercialization challenges. ABx Group remains in early commercialization stage with substantial capital requirements, execution dependencies, and market realization challenges. The $2.7 million bauxite payment and RETi engagement represent positive progress, but do not guarantee ultimate commercial success. Success requires execution of supply agreements, cost-effective production achievement, sustained global demand, successful capital raising, and effective project management.

For investors with conviction in the critical minerals supply chain diversification theme and appropriate tolerance for early-stage company risk, ABx Group offers exposure to a company demonstrating real progress in commercialization and benefiting from favorable supply-demand dynamics. The RETi validation provides tangible evidence of product quality and active customer engagement, positioning ABx favorably among emerging Western rare earth suppliers. Upcoming catalysts including RETi supply agreement execution, ALCORE pilot completion and scaling, and bauxite production ramp-up will determine whether ABx Group can realize its significant potential within the global critical minerals transition.

LONG-TERM INVESTMENT PERSPECTIVE: Critical Minerals Thematic Supports Multi-Year Growth

From a long-term investment perspective, ABx Group's positioning aligns with transformative global trends that appear structural and multi-decade in duration. The transition to electric mobility, renewable energy, advanced manufacturing, and sustainable materials represents a fundamental shift in global raw materials demand that will persist regardless of economic cycles.

Rare earth elements are non-substitutable components in these applications, and Western supply chain diversification is becoming a strategic imperative rather than discretionary preference. Government policy, corporate ESG commitments, and regulatory requirements all support sustained demand for alternative suppliers. ABx Group's combination of rare earth resources, demonstrated processing technology capability, alternative materials (fluorine chemicals, bauxite), and Australian operational base positions the company to benefit from sustained structural demand.

However, investors must maintain realistic assessment of risks and timelines. Project commercialization remains in early stage, capital requirements are substantial, and execution risks exist. Success depends upon timely commercial agreements, cost-effective production achievement, sustained global demand, and successful capital raising. Long-term investors should view ABx as a multi-year investment with significant upside potential but also meaningful downside risk.

QUESTIONS INVESTORS ARE ASKING ABOUT ABx GROUP

Q1: What exactly is mixed rare earth carbonate (MREC) and why does RETi's validation matter?

A: MREC is a processed rare earth product containing multiple rare earth elements in carbonate form extracted from ionic adsorption clay deposits. RETi's validation matters because it confirms ABx's MREC meets technical specifications for their proprietary Solid-Phase Extraction and High-Performance Liquid Chromatography separation processes. This third-party validation from a US processor reduces technical risk, demonstrates product quality at scale, and opens commercial discussions with a known industry participant.

Q2: What is the Deep Leads Rare Earths Project and why is it economically advantaged compared to other rare earth deposits?

A: Deep Leads is an ionic adsorption clay rare earth resource located in northern Tasmania. Ionic adsorption clays offer lower extraction costs compared to other rare earth deposit types (such as hard rock carbonatites or monazite sands), while producing high-quality MREC suitable for downstream processing. The MREC product quality has been validated by RETi testing, demonstrating that Deep Leads resources support commercially acceptable products.

Q3: How much revenue can ABx Group expect from RETi supply if they reach supply agreement?

A: The company has not disclosed specific supply volumes, pricing, or revenue figures for potential RETi supply. Supply agreement terms have not been publicly announced. Investors should await binding supply agreement announcements before projecting revenue impact. Supply agreements in the rare earth sector typically involve multi-year terms with volume commitments and price mechanisms tied to commodity indices.

Q4: What is ALCORE and when could it contribute meaningful revenue to ABx Group?

A: ALCORE is ABx Group's clean fluorine chemical production initiative with a pilot plant facility in Bell Bay, Tasmania. The company has not disclosed ALCORE revenue timelines or production capacity targets. Pilot plant phase typically requires 1-2 years before commercial-scale production becomes feasible. Success requires demonstration of commercial viability, cost competitiveness, and customer demand.

Q5: What does the $2.7 million bauxite payment signify about ABx Group's revenue capability?

A: The $2.7 million initial payment from Good Importing International demonstrates that ABx Group can execute supply agreements and generate near-term revenue. This validates the company's ability to commercialize assets and suggests additional bauxite payments are possible as production ramps. Bauxite represents a near-term revenue opportunity, providing cash flow while rare earth and ALCORE projects develop.

Q6: Is China still a dominant force in rare earth supply and does that support ABx Group's commercial opportunity?

A: Yes, China controls approximately 80 percent of global rare earth processing capacity and has periodically imposed export restrictions. This concentration creates supply chain risk that Western governments and corporations are actively addressing through supply diversification initiatives and critical minerals policy. ABx Group's Australian rare earth assets and validated processing capability position the company favorably within this trend. Customer demand for alternative suppliers supports commercial opportunity.

Q7: What are the capital requirements for ABx Group to reach commercial production?

A: The company has not disclosed total capital requirements or detailed funding timelines. Rare earth processing projects typically require tens to hundreds of millions of dollars depending upon production scale and technology. ABx Group will likely require equity capital raises, debt financing, or strategic partnerships to fund project development and scaling. The bauxite revenue may assist capital requirements.

Q8: How is ABx Group's geographic position in Tasmania advantageous for materials projects?

A: Tasmania offers multiple advantages including proximity to Australian east coast markets and Asian markets, established mining and processing infrastructure, regulatory framework favorable to mining and critical minerals development, political support for domestic critical minerals projects, and existing industrial facilities (Bell Bay for ALCORE). Geographic advantage supports lower logistics costs and regulatory alignment.

Q9: What are the biggest execution risks for ABx Group's rare earth and materials projects?

A: Key execution risks include: (1) scaling production from pilot assessment to commercial volumes, (2) achieving targeted production costs and operating margins, (3) obtaining environmental and heritage permits within timelines, (4) sustaining and expanding RETi customer engagement, (5) securing adequate project financing without excessive dilution, (6) managing rare earth commodity price volatility, and (7) competing with established producers.

Q10: Is ABx Group a good long-term investment for critical minerals thematic exposure?

A: ABx Group offers rare earth and critical materials supply chain exposure aligned with structural global demand themes driven by electrification, renewable energy, and advanced manufacturing. The company demonstrates progress through RETi validation and bauxite revenue. However, the company remains in early commercialization stage with substantial development risk and capital requirements. Investors should conduct thorough due diligence, understand their risk tolerance, recognize execution risks, and view ABx as a multi-year conviction investment rather than short-term trade.